إعلان
إعلان
PTCT
PTC Therapeutics, Inc.
76.69
USDبرعاية
+0.73
+0.96%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
75.50
-1.19
-1.55%
تقارير أرباح PTCT
النسبة الإيجابية المفاجئة
PTCT تفوق 14 من 40 آخر التقديرات.
35%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$241.29M
/-$0.55
التغير الضمني من Q3 25 (Revenue/ EPS)
+14.35%
/-375.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+13.19%
/-74.42%
PTC Therapeutics, Inc. earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, PTCT reported earnings of 0.20 USD per share (EPS) for Q3 25, beating the estimate of -1.39 USD, resulting in a 114.33% surprise. Revenue reached 211.01 مليون, compared to an expected 188.96 مليون, with a 11.67% difference. The market reacted with a +5.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.55 USD, with revenue projected to reach 241.29 مليون USD, implying an decrease of -375.00% EPS, and increase of 14.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were PTC Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PTC Therapeutics, Inc. reported EPS of $0.20, beating estimates by 114.33%, and revenue of $211.01M, 11.67% above expectations.
How did the market react to PTC Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved up 5.98%, changed from $67.72 before the earnings release to $71.77 the day after.
When is PTC Therapeutics, Inc. expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for PTC Therapeutics, Inc.'s next earnings report?
Based on 17
analysts, PTC Therapeutics, Inc. is expected to report EPS of -$0.55 and revenue of $241.29M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان